No recent ownership filings for this insider.
| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2014 | Jan 5, 2015 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 20.0 | -2,802 | -12.36% | ✗ | $271.8K |
| Nov 18, 2014 | Nov 19, 2014 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 7.5 | -10,000 | -63.81% | ✓ | $906.7K |
| Aug 18, 2014 | Aug 20, 2014 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 7.5 | -13,500 | -70.46% | ✓ | $909K |
| May 19, 2014 | May 21, 2014 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 7.5 | -13,500 | -70.59% | ✓ | $780.7K |
| Feb 19, 2014 | Feb 20, 2014 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 5.0 | -20,400 | -78.50% | ✓ | $1.6M |
| Jan 23, 2014 | Jan 27, 2014 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 40.0 | -3,698 | -22.85% | ✗ | $330.9K |
| Dec 30, 2013 | Jan 2, 2014 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 22.5 | -930 | -5.43% | ✗ | $60K |
| Nov 13, 2013 | Nov 15, 2013 | ALNYLAM PHARMACEUTICALS, INC. | SVP, Chief Business Officer | Sell | 7.5 | -13,500 | -50.25% | ✓ | $720.3K |